Redhill Biopharma Ltd logo

Redhill Biopharma Ltd - ADR

1
NAS:RDHL (Israel)   ADR
$ 0.62 +0.076101 (+14.1%) 03:59 PM EST
At Loss
P/B:
0.61
Market Cap:
$ 16.04M
Enterprise V:
$ 10.99M
Volume:
2.13M
Avg Vol (2M):
1.55M
Also Trade In:
Volume:
2.13M
At Loss
Avg Vol (2M):
1.55M

Business Description

Redhill Biopharma Ltd logo
Redhill Biopharma Ltd
NAICS : 325412
ISIN : US7574681034

Share Class Description:

RDHL: ADR
Description
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults, Talicia for the treatment of Helicobacter pylori infection in adults, and Aemcolo for the treatment of travelers' diarrhea in adults. Its key clinical late-stage development programs include RHB-104 for Crohn's disease; RHB-204, for pulmonary nontuberculous mycobacteria infections; RHB-102 (Bekinda) with positive results from a first Phase 3 study for acute gastroenteritis and gastritis; Opaganib (Yeliva); RHB-106, an encapsulated bowel preparation and RHB-107, a Phase 2-stage serine protease inhibitor targeting cancer and inflammatory gastrointestinal diseases.
Name Current Vs Industry Vs History
Cash-To-Debt 3.07
Equity-to-Asset 0.1
Debt-to-Equity 0.66
Debt-to-EBITDA 0.02
Interest Coverage 0.21
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -9.54
Distress
Grey
Safe
Beneish M-Score 1.26
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 47.52
9-Day RSI 38.16
14-Day RSI 36.88
6-1 Month Momentum % -25.26
12-1 Month Momentum % -92.49

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.96
Quick Ratio 0.78
Cash Ratio 0.25
Days Inventory 164.46
Days Sales Outstanding 232.9
Days Payable 74.42

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -38.3
Shareholder Yield % 95.17

Financials (Next Earnings Date:2024-03-17 Est.)

RDHL's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:RDHL

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Redhill Biopharma Ltd Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 35.745
EPS (TTM) ($) -3.807
Beta 5.37
Volatility % 385.13
14-Day RSI 36.88
14-Day ATR ($) 0.062931
20-Day SMA ($) 0.549405
12-1 Month Momentum % -92.49
52-Week Range ($) 0.257 - 9.208
Shares Outstanding (Mil) 29.7

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Redhill Biopharma Ltd Filings

Filing Date Document Date Form
No Filing Data

Redhill Biopharma Ltd Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Redhill Biopharma Ltd Frequently Asked Questions

What is Redhill Biopharma Ltd(RDHL)'s stock price today?
The current price of RDHL is $0.62. The 52 week high of RDHL is $9.21 and 52 week low is $0.26.
When is next earnings date of Redhill Biopharma Ltd(RDHL)?
The next earnings date of Redhill Biopharma Ltd(RDHL) is 2024-03-17 Est..
Does Redhill Biopharma Ltd(RDHL) pay dividends? If so, how much?
Redhill Biopharma Ltd(RDHL) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1